Phthisis Signs Distribution Deal for India | GenomeWeb

NEW YORK (GenomeWeb News) – Phthisis Diagnostics announced that it has signed a distribution deal covering India.

The deal with Genetix Biotech, headquartered in New Delhi, is the first distribution deal by Phthisis in Asia. Genetix, which has more than 30 distributors in India and Southeast Asia, will handle Phthisis' entire product line, including those in development, as part of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.